Stay always informed
Interested in our articles? Get the latest information and analysis straight to your email. Sign up for our newsletter.
On 5 July 2023, the European Commission (DG SANTE) published a law proposal to deregulate new GMOs (products from genome editing techniques, also called ‘new genomic techniques’ or NGTs). The Commission’s proposal was met with strong criticism as it is scientifically unfounded and it creates more risks for the environment and health.
At the request of Corporate Europe Observatory (CEO), Artemisia law firm has analysed the Commission’s proposal. The full legal analysis can be found here and a summary here.
A Q&A session with the author via zoom is being held on Wednesday 8 November 2023 at 9.30am CEST. You can register by sending an email to nina@corporateeurope.org
According to the legal analysis:
It should be noted that using these criteria, the large majority of NGTs currently in the pipeline will be deregulated, according to research by the German federal agency for nature conservation (BfN).
In addition, plants obtained by further cross-breeding with such deregulated Category 1 varieties would also get a complete free ride. Interventions in the genome of plants will in fact be totally unlimited, and the proposed definition of the “breeder’s gene pool” even allows for the introduction of a wide range of foreign genes into NGT plants.
The full legal analysis can be found here and a summary here.
You are kindly invited to attend a Q&A session by zoom with the author of the analysis, Attorney Blanche Magarinos-Rey:
ENDS
For more information contact:
Nina Holland, Corporate Europe Observatory researcher: nina@corporateeurope.org, phone: +32 (0) 466 294420